Therapeutic molecules
US11236174B2 · kind B2 · utility
7Cited by
1References
10Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jan 12, 2017 |
| Grant date | Feb 1, 2022 |
| Priority date | — |
| Expiry date | Jul 9, 2037 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2317/94
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention relates to binding molecules that bind specifically to prostate specific membrane antigen (PSMA), in particular, single human variable heavy chain domain antibodies and related methods for treatment of cancer.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.